The possible roles of environmental factors and the aryl hydrocarbon receptor in the prevalence of thyroid diseases in Vietnam era veterans

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 18, Issue 5, 2011, Pages 315-320

  Spaulding, Stephen W ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

2,3,7,8 tetrachlorodibenzo p dioxin (TCDD); aryl hydrocarbon receptor (Ah R); dendritic cell; Graves' disease; regulatory T cell; T helper17 cell; T helper22 cell

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; TRANSCRIPTION FACTOR;

AUTOIMMUNE THYROIDITIS; DENDRITIC CELL; ENVIRONMENTAL FACTOR; GRAVES DISEASE; HASHIMOTO DISEASE; LEUKEMIA; LYMPHOMA; PREVALENCE; REGULATORY T LYMPHOCYTE; REVIEW; TH17 CELL; TH22 CELL; THYROID DISEASE; VETERAN;

ANIMALS; ENVIRONMENTAL EXPOSURE; HUMANS; RECEPTORS, ARYL HYDROCARBON; T-LYMPHOCYTES, REGULATORY; TETRACHLORODIBENZODIOXIN; TH17 CELLS; THYROID DISEASES; VETERANS; VIETNAM CONFLICT;

EID: 80052429036     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0b013e32834a8764     Document Type: Review

References (35)

1. Brtko J, Dvorak Z. Role of retinoids, rexinoids and thyroid hormone in the expression of cytochrome P450enzymes. Curr Drug Metab 2011; 12:71-88.
2. Baccarelli A, Giacomini SM, Corbetta C, et al. Neonatal thyroid function in Seveso 25 years after maternal exposure to dioxin. PLo S Med 2008; 5:e161.
3. Pavuk M, Schecter AJ, Akhtar FA, Michalek JE. Serum 2,3,7,8- tetrachlorodi-benzo-p-dioxin (TCDD) levels and thyroid function in Air Force veterans of the Vietnam war. Ann Epidemiol 2003; 13:335-343. (Pubitemid 36773169)
4. CDC Vietnam Experience Study, Health Status of Vietnam Veterans. Volume III, medical examination V.3, part 4:171-175 and part 6:332-335, 1986. http://www.cdc.gov/nceh/veterans/default1c.htm. [Accessed 11 July2011]
5. Bufalo NE, Santos RB, Cury AN, et al. Genetic polymorphisms associated with cigarette smoking andthe riskof Graves' disease. Clin Endocrinol 2008; 68:982-987. (Pubitemid 351703938)
6. Vondracek J, Umannova L, Machala M. Interactions of the aryl hydrocarbon receptor with inflammatory mediators: beyond CYP1A regulation. Curr Drug Metab 2011; 12:89-103.
7. Petrick JS, Klasseen CD. Importance of hepatic induction of constitutive androstane receptor and other transcription factors that regulate xenobiotic metabolism and transport. Drug Metab Disposition 2007; 35:1806-1815. (Pubitemid 47481572)
8. Gilot D, Le Meur N, Giudicelli F, et al. RNAi-based screening identifies kinases interfering with dioxin-mediated up-regulation of CYP1A1 activity. PLo S ONE 2011; 6:e1 8261.
9. Chen S, Beaton D, Nguyen N, et al. Tissue-specific, inducible, and hormonal control of the human UDP-glucuronosyltransferase-1 (UGT1) locus. J Biol Chem 2005; 280:37547-37557. (Pubitemid 41642363)
10. Svoboda M, Riha J, Wlcek K, et al. Organic anion transporting polypeptides (OATPs): regulation of expression and function. Curr Drug Metab 2011; 12:139-153.
11. Yoshizawa K, Nigel J,Walker NJ, et al.Thyroidfollicularlesions induced byoral treatment for 2 years with 2,3,7,8-tetrachlorodibenzo-p-dioxin and dioxin-like compounds in female Harlan Sprague-Dawley rats. Toxicol Pathol 2010; 38:1037-1050.
12. Nguyen TA, Hoivik D, Lee J-E, Safe S. Interactions of nuclear receptor coactivator/corepressor proteinswith thearyl hydrocarbon receptorcomplex. Arch Biochem Biophys 1999; 367:250-257. (Pubitemid 29394172)
13. Yamada-Okabe T, Aono T, Sakai H, et al. 2,3,7,8-tetrachlorodibenzo-p- dioxin augments the modulation of gene expression mediated by the thyroid hor-mone receptor. Toxicol Appl Pharmacol 2004; 194:201-210. (Pubitemid 38175282)
14. Pocar P, Klonisch T, Brandsch C, et al. Ah R-agonist-induced transcriptional changes of genes involved in thyroid function in primary porcine thyrocytes. Toxicol Sci 2006; 89:408-414. (Pubitemid 43125998)
15. Von Bubnoff D, Scheler M, Wilms H, et al. Identification of IDO-positive and IDO-negative human dendriticcellsafteractivation by various proinflammatory stimuli. J Immunol 2011; 186:6701-6709.
16. Mezrich JD, Fechner JH, Zhang X, et al. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J Immunol 2010; 185:3190-3198.
17. Nguyen NT, Kimura A, Nakahama T, et al. Aryl hydrocarbon receptor nega-tively regulates dendritic cell immunogenicity via kynurenine-dependent mechanism. Proc Nat Acad Sci U S A 2010; 107:19961-19966.
18. Hoechst B, Gamrekelashvili J, Manns MP, et al. Plasticity of human Th17 cells and i Tregs is orchestrated by different subsets of myeloid cells. Blood 2011; 117:6532-6541.
19. Zhang L, Ma J, Takeuch M, Usui Y, et al. Suppression of experimental autoimmune uveoretinitis by inducing differentiation of regulatory T cells via activation of aryl hydrocarbon receptor. Invest Ophthalmol Vis Sci 2010; 51:2109-2117.
20. Quintana FJ, Murugaiyan G, Farez MF, et al. An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmuneencephalomyelitis. Proc Nat Acad Sci US A 2010; 107:20768-20773.
21. Ramirez J-M, Brembilla NC, Sorg O, et al. Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells. Eur J Immunol 2010; 40:2450-2459.
22. Brembilla NC, Ramirez J-M, Chicheportiche R, et al. In-vivo dioxin favors interleukin-22 production by human CD4+ T cells in an aryl hydrocarbon receptor (Ah R)-dependent manner. PLo S ONE 2011; 6:e18741.
23. h17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008; 453: 65-67.
24. Kuestner RE, Taft DW, Haran A, et al. Identification of the IL-1 7 receptor related molecule, IL-q17RC as the receptor for IL-17F. J Immunol 2007; 179:5462-5473.
25. Kunz S, Wolk K, Witte E, et al. Interleukin (IL)-19, IL-20 and IL-24 are produced by and act on keratinocytes and are distinct from classical ILs. Exp Dermatol 2006; 15:991-1004. (Pubitemid 44688369)
26. h17 lymphocytes in Hashimoto's thyroiditis. J Clin Endocrinol Metab 2010; 95:953-962.
27. Nanba T, Watanabe M, Inoue N, Iwatani Y. Increases ofthe Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease. Thyroid 2009; 19:495-501.
28. Shi Y,Wang H,Su Z, et al. Differentiation imbalanceof Th1/Th17 in peripheral blood mononuclear cells might contribute to pathogenesis of Hashimoto's thyroiditis. Scand J Immunol 2010; 72:250-255.
29. + regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves' disease. J Immunol 2011; 186:4734-4743.
30. Horie I, Abiru N, Nagayama Y, et al. T helper type 17 immune response plays an indispensable role for development of iodine-induced autoimmune thyr-oiditis in nonobese diabetic-H2h4 mice. Endocrinology 2009; 150:5135-5142.
31. Horie I, Abiru N, Saitoh O, et al. Distinct role of T helper type 17 immune response for Graves' hyperthyroidism in mice with different genetic back-grounds. Autoimmunity 2011; 44:159-165.
32. Zhou Z, Bi M, Fan C, et al. Regulatory T cells but not T helper 17 cells are modulated in an animal model of Graves' hyperthyroidism. Clin Exp Med 2011; doi: 10.1007/s10238-011-0137-6.
33. Belin RM, Astor BC, Powe NR, Ladenson PW. Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concen-tration suppression in the third national health and nutrition examination survey (NHANES III). J Clin Endo Metab 2004; 89:6077-6086. (Pubitemid 39628417)
34. Asvold BO, Bjoro T, Nilsen TI, Vatten LJ. Tobacco smoking and thyroid function: a population-based study. Arch Intern Med 2007; 167:1428-1432. (Pubitemid 47052443)
35. Chen K, Pociask DA, Mc Aleer JP, et al. IL-1 7RA is required for CCL2 expression, macrophage recruitment, and emphysema in response to cigar-ette smoke. PLo S ONE 2011; 6:e20333.